MedTrace Logo

Near Infrared Spectroscopy for Blood Glucose Measurement in Critical Care Settings

NCT01168089 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2010-07-22

No results posted yet for this study

Summary

Luminous Medical, the Sponsor is developing a glucose monitor for the critical care setting. The Sponsor's ultimate goal is to provide a near-continuous blood glucose monitor that automatically measures glucose. In this study, Luminous will evaluate the performance of the near-infrared measurement in blood samples collected from patients in the intensive care unit setting.

Conditions

  • Critical Care

Sponsors & Collaborators

  • Luminous Medical

    collaborator INDUSTRY

  • InLight Solutions

    lead INDUSTRY

Principal Investigators

  • Mark Rohrscheib, M.D. · UNMHSC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01168089 on ClinicalTrials.gov